| Agonist of RORA attenuates nonalcoholic fatty liver progression in mice via up-regulation of MicroRNA 122 C Chai, B Cox, D Yaish, D Gross, N Rosenberg, F Amblard, Z Shemuelian, ... Gastroenterology 159 (3), 999-1014. e9, 2020 | 61 | 2020 |
| The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice P Fishman, S Cohen, I Itzhak, J Amer, A Salhab, F Barer, R Safadi International journal of molecular medicine 44 (6), 2256-2264, 2019 | 37 | 2019 |
| Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis A Salhab, J Amer, Y Lu, R Safadi Gut 71 (7), 1373-1385, 2022 | 31 | 2022 |
| Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease J Amer, A Salhab, M Noureddin, S Doron, L Abu‐Tair, R Ghantous, ... Hepatology Communications 2 (3), 285-298, 2018 | 31 | 2018 |
| CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis R Greenman, M Segal-Salto, N Barashi, O Hay, A Katav, O Levi, I Vaknin, ... JCI insight 8 (12), 2023 | 9 | 2023 |
| Gundelia tournefortii inhibits hepatocellular carcinoma progression by lowering gene expression of the cell cycle and hepatocyte proliferation in immunodeficient mice J Amer, A Salhab, N Jaradat, S Abdallah, H Aburas, S Hattab, M Ghanim, ... Biomedicine & Pharmacotherapy 156, 113885, 2022 | 8 | 2022 |
| Ecballium elaterium improved stimulatory effects of tissue-resident NK cells and ameliorated liver fibrosis in a thioacetamide mice model M Ghanim, J Amer, A Salhab, N Jaradat Biomedicine & Pharmacotherapy 150, 112942, 2022 | 6 | 2022 |
| 25 (OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor A Salhab, J Amer, L Yinying, R Safadi BMC gastroenterology 20, 1-8, 2020 | 6 | 2020 |
| A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation J Amer, A Salhab, S Doron, G Morali, R Safadi Cytometry Part A 93 (4), 427-435, 2018 | 6 | 2018 |
| The anti-inflammatory and anto-fibrogenic effects of namodenoson in NAFLD/NASH animal models P Fishman, A Salhab, S Cohen, J Amer, I Itzhak, F Barer, R Safadi Journal of Hepatology 68, S349-S350, 2018 | 5 | 2018 |
| Arum palaestinum delays hepatocellular carcinoma proliferation through the PI3K-AKT-mTOR signaling pathway and exhibits anticoagulant effects with … M Dwikat, J Amer, N Jaradat, A Salhab, AA Rahim, M Qadi, A Aref, ... Frontiers in Pharmacology 14, 1180262, 2023 | 3 | 2023 |
| The immune interplay between thyroid papillary carcinoma and hepatic fibrosis N Muhanna, J Amer, A Salhab, JY Sichel, R Safadi Plos one 10 (7), e0132463, 2015 | 3 | 2015 |
| P0502: Recombinant neuroligin 4 (NLG4) activates NK cells and attenuates fibrogenesis in nonalcoholic fatty liver disease J Amer, A Salhab, R Safadi Journal of Hepatology, S503, 2015 | 1 | 2015 |
| O155 HOMOZYGOUS NLG4 (KO) MICE SHOWED A DECREASED INFLAMMATORY AND FIBROTIC PROFILE AND IS ASSOCIATED WITH NK CELLS INCREASED KILLING ACTIVITY J Amer, S Doron, A Salhab, N Ilani, R Safadi Journal of Hepatology 1 (60), S64, 2014 | 1 | 2014 |
| THU-197 Restoration of natural killer cell antifibrotic activity via a novel immune target; the Neuroligin-4/β-Neurexin pathway J Amer, A Salhab, R Safadi Journal of Hepatology 80, S564, 2024 | | 2024 |
| FRI-408 Statins in untreated chronic HBV link with improved survival, liver outcome and inflammation: a large multicenter retrospective real-world cohort study M Suki, T Safadi, Y Milgrom, M Masarowah, W Hazo, Y Tiram, J Amer, ... Journal of Hepatology 80, S779, 2024 | | 2024 |
| OS-100 Elevated expressions of NTCP on NK cells from liver fibrosis of metabolic dysfunction-associated steatohepatitis patients are associated with increased bile acid uptake … A Salhab, J Amer, R Safadi Journal of Hepatology 80, S63, 2024 | | 2024 |
| THU-547 Ex-vivo translational assay of hepatic stellate cells using patientderived serum characterizes the anti-fibrotic activity of CM-101 J Amer, A Salhab, R Greenman, T Snir, A Katav, R Aricha, M Frankel, ... Journal of Hepatology 80, S268-S269, 2024 | | 2024 |
| LBP-035 Luji-1 reduces fibrosis by blocking Neuroligin-4 and β-neurexin and overexpressing thyroid hormone receptor-b, suggesting Rezdiffra sensitization and synergism in … J Amer, A Salhab, B Saffouri, A Imam, A Khalaileh, R Safadi Journal of Hepatology 80, S95, 2024 | | 2024 |
| The immune and metabolic treatment approach of using testosterone on mice models of liver injury J Amer, A Salhab, H Snobar, Y Alhabil Frontiers in Pharmacology 14, 1219709, 2023 | | 2023 |
